{"id": "article-20936_0", "title": "Eisenmenger Syndrome -- Continuing Education Activity", "content": "Eisenmenger syndrome (ES) is a constellation of symptoms that arise from a congenital heart defect and result in large anatomic shunts. Due to anatomic variations present at birth, hemodynamic forces initially result in a left-right shunt, which develops into severe pulmonary arterial hypertension (PAH) and elevated vascular resistance. Ultimately, due to increased pulmonary vascular resistance, the left-to-right shunt will become a right-to-left shunt, resulting in significant hypoxemia and cyanosis. This activity a discussion of the evaluation and treatment of Eisenmenger syndrome and further defines the role of the interprofessional team in managing patients with this condition.", "contents": "Eisenmenger Syndrome -- Continuing Education Activity. Eisenmenger syndrome (ES) is a constellation of symptoms that arise from a congenital heart defect and result in large anatomic shunts. Due to anatomic variations present at birth, hemodynamic forces initially result in a left-right shunt, which develops into severe pulmonary arterial hypertension (PAH) and elevated vascular resistance. Ultimately, due to increased pulmonary vascular resistance, the left-to-right shunt will become a right-to-left shunt, resulting in significant hypoxemia and cyanosis. This activity a discussion of the evaluation and treatment of Eisenmenger syndrome and further defines the role of the interprofessional team in managing patients with this condition."}
{"id": "article-20936_1", "title": "Eisenmenger Syndrome -- Continuing Education Activity", "content": "Objectives: Review the pathophysiology of Eisenmenger syndrome. Identify patients considered high risk for Eisenmenger syndrome Describe the physical exam findings associated with Eisenmenger syndrome. Summarize the importance of improving care coordination amongst the interprofessional team to enhance the delivery of care for patients affected with Eisenmenger syndrome. Access free multiple choice questions on this topic.", "contents": "Eisenmenger Syndrome -- Continuing Education Activity. Objectives: Review the pathophysiology of Eisenmenger syndrome. Identify patients considered high risk for Eisenmenger syndrome Describe the physical exam findings associated with Eisenmenger syndrome. Summarize the importance of improving care coordination amongst the interprofessional team to enhance the delivery of care for patients affected with Eisenmenger syndrome. Access free multiple choice questions on this topic."}
{"id": "article-20936_2", "title": "Eisenmenger Syndrome -- Introduction", "content": "Eisenmenger syndrome\u00a0(ES)\u00a0is a\u00a0constellation of symptoms that\u00a0arise\u00a0from a\u00a0congenital heart defect\u00a0and result in large anatomic shunts. Due to anatomic variations\u00a0present at birth, hemodynamic\u00a0forces\u00a0initially result in\u00a0a left-right shunt,\u00a0which develops into\u00a0severe pulmonary arterial hypertension\u00a0(PAH)\u00a0and elevated vascular\u00a0resistance. Ultimately,\u00a0due to increased pulmonary vascular resistance,\u00a0the left-to-right shunt will become a right-to-left shunt, resulting in significant hypoxemia and cyanosis.", "contents": "Eisenmenger Syndrome -- Introduction. Eisenmenger syndrome\u00a0(ES)\u00a0is a\u00a0constellation of symptoms that\u00a0arise\u00a0from a\u00a0congenital heart defect\u00a0and result in large anatomic shunts. Due to anatomic variations\u00a0present at birth, hemodynamic\u00a0forces\u00a0initially result in\u00a0a left-right shunt,\u00a0which develops into\u00a0severe pulmonary arterial hypertension\u00a0(PAH)\u00a0and elevated vascular\u00a0resistance. Ultimately,\u00a0due to increased pulmonary vascular resistance,\u00a0the left-to-right shunt will become a right-to-left shunt, resulting in significant hypoxemia and cyanosis."}
{"id": "article-20936_3", "title": "Eisenmenger Syndrome -- Introduction", "content": "PAH is a mean pulmonary arterial pressure greater than 25 mmHg while resting or 30 mmHg when exercising. This may occur in large shunts or complex, unrepaired congenital heart disease as early as the first decade of life.", "contents": "Eisenmenger Syndrome -- Introduction. PAH is a mean pulmonary arterial pressure greater than 25 mmHg while resting or 30 mmHg when exercising. This may occur in large shunts or complex, unrepaired congenital heart disease as early as the first decade of life."}
{"id": "article-20936_4", "title": "Eisenmenger Syndrome -- Etiology", "content": "Any heart defect that leads to the development of PAH can cause Eisenmenger syndrome. This is commonly seen in\u00a0atrial septal defects (ASD),\u00a0ventricular septal defects (VSD),\u00a0atrioventricular\u00a0septal defects (AVSD),\u00a0and\u00a0patent ductus arteriosus (PDA), but can occur in more complex lesions as well.\u00a0Unrepaired Tetralogy of Fallot (ToF) may also result in Eisenmenger syndrome. Without early repair, reversal of a left-to-right shunt may result in a bidirectional or right-to-left shunt. The subsequent hypoxemia due to this shunt may not be responsive to oxygen.", "contents": "Eisenmenger Syndrome -- Etiology. Any heart defect that leads to the development of PAH can cause Eisenmenger syndrome. This is commonly seen in\u00a0atrial septal defects (ASD),\u00a0ventricular septal defects (VSD),\u00a0atrioventricular\u00a0septal defects (AVSD),\u00a0and\u00a0patent ductus arteriosus (PDA), but can occur in more complex lesions as well.\u00a0Unrepaired Tetralogy of Fallot (ToF) may also result in Eisenmenger syndrome. Without early repair, reversal of a left-to-right shunt may result in a bidirectional or right-to-left shunt. The subsequent hypoxemia due to this shunt may not be responsive to oxygen."}
{"id": "article-20936_5", "title": "Eisenmenger Syndrome -- Epidemiology", "content": "Eisenmenger syndrome is a relatively rare disorder that is usually seen in persons with poor healthcare access (i.e., rural/underserved areas), in whom large anatomical defects may go undetected for many years.", "contents": "Eisenmenger Syndrome -- Epidemiology. Eisenmenger syndrome is a relatively rare disorder that is usually seen in persons with poor healthcare access (i.e., rural/underserved areas), in whom large anatomical defects may go undetected for many years."}
{"id": "article-20936_6", "title": "Eisenmenger Syndrome -- Pathophysiology", "content": "The most common defects leading to\u00a0Eisenmenger syndrome are ASD, VSD, and PDA defects. The following three main processes result in the ultimate reversal of a left-to-right into a right-to-left shunt: Vasoconstriction due to imbalances\u00a0in pulmonary\u00a0vascular tone,\u00a0followed by Vascular remodeling  due\u00a0to the proliferation of pulmonary vascular smooth muscle,\u00a0and\u00a0finally Thrombosis caused by the increased resistance of blood flow.", "contents": "Eisenmenger Syndrome -- Pathophysiology. The most common defects leading to\u00a0Eisenmenger syndrome are ASD, VSD, and PDA defects. The following three main processes result in the ultimate reversal of a left-to-right into a right-to-left shunt: Vasoconstriction due to imbalances\u00a0in pulmonary\u00a0vascular tone,\u00a0followed by Vascular remodeling  due\u00a0to the proliferation of pulmonary vascular smooth muscle,\u00a0and\u00a0finally Thrombosis caused by the increased resistance of blood flow."}
{"id": "article-20936_7", "title": "Eisenmenger Syndrome -- Histopathology", "content": "Histological examination of the vasculature in Eisenmenger syndrome would resemble other forms of pulmonary hypertension. Increased proliferation of vascular smooth muscle, evidence of lung parenchymal scarring (pulmonary fibrosis), and decreased luminal\u00a0caliber due to cellular proliferation\u00a0in the vascular walls all\u00a0are indicative of a PAH process.", "contents": "Eisenmenger Syndrome -- Histopathology. Histological examination of the vasculature in Eisenmenger syndrome would resemble other forms of pulmonary hypertension. Increased proliferation of vascular smooth muscle, evidence of lung parenchymal scarring (pulmonary fibrosis), and decreased luminal\u00a0caliber due to cellular proliferation\u00a0in the vascular walls all\u00a0are indicative of a PAH process."}
{"id": "article-20936_8", "title": "Eisenmenger Syndrome -- History and Physical", "content": "The most common presentation in Eisenmenger syndrome is a patient with known congenital heart disease (CHD) presenting with worsening exertional dyspnea. Other common complaints may include swelling, volume retention, syncope, worsening cyanosis, palpitations, or hemoptysis.\u00a0Due to the increase in red blood cell volume from chronic hypoxemia, patients\u00a0also\u00a0may present with polycythemia/viscosity-type symptoms such as dizziness, headaches, vision changes, end-organ damage, stroke.", "contents": "Eisenmenger Syndrome -- History and Physical. The most common presentation in Eisenmenger syndrome is a patient with known congenital heart disease (CHD) presenting with worsening exertional dyspnea. Other common complaints may include swelling, volume retention, syncope, worsening cyanosis, palpitations, or hemoptysis.\u00a0Due to the increase in red blood cell volume from chronic hypoxemia, patients\u00a0also\u00a0may present with polycythemia/viscosity-type symptoms such as dizziness, headaches, vision changes, end-organ damage, stroke."}
{"id": "article-20936_9", "title": "Eisenmenger Syndrome -- History and Physical", "content": "Digital clubbing is often seen in these patients. Digital clubbing that is more pronounced in the lower extremities\u00a0can occur in the setting of shunt physiology associated with patent\u00a0ductus arteriosus and the delivery of unoxygenated\u00a0blood distal to the origin of the left subclavian artery. Dermatologic\u00a0manifestations associated with Eisenmenger's syndrome may include plethora, livedo reticularis, profound acrocyanosis, urate depositions, ecchymosis, and ischemic skin ulcerations. Ascites and right upper quadrant tenderness, as a result of hepatic congestion and gallbladder pathology, may be present on abdominal exam.", "contents": "Eisenmenger Syndrome -- History and Physical. Digital clubbing is often seen in these patients. Digital clubbing that is more pronounced in the lower extremities\u00a0can occur in the setting of shunt physiology associated with patent\u00a0ductus arteriosus and the delivery of unoxygenated\u00a0blood distal to the origin of the left subclavian artery. Dermatologic\u00a0manifestations associated with Eisenmenger's syndrome may include plethora, livedo reticularis, profound acrocyanosis, urate depositions, ecchymosis, and ischemic skin ulcerations. Ascites and right upper quadrant tenderness, as a result of hepatic congestion and gallbladder pathology, may be present on abdominal exam."}
{"id": "article-20936_10", "title": "Eisenmenger Syndrome -- Evaluation", "content": "All patients with suspicion for Eisenmenger syndrome should undergo a detailed history and physical, with\u00a0particular attention\u00a0on determining triggers for PAH. Patients should also undergo an evaluation to determine the degree of PAH as well as ventricular function.\u00a0As there is evidence supporting symptomatic improvement with vasodilator therapy as in PAH, patients should also undergo vasoreactivity testing.", "contents": "Eisenmenger Syndrome -- Evaluation. All patients with suspicion for Eisenmenger syndrome should undergo a detailed history and physical, with\u00a0particular attention\u00a0on determining triggers for PAH. Patients should also undergo an evaluation to determine the degree of PAH as well as ventricular function.\u00a0As there is evidence supporting symptomatic improvement with vasodilator therapy as in PAH, patients should also undergo vasoreactivity testing."}
{"id": "article-20936_11", "title": "Eisenmenger Syndrome -- Evaluation", "content": "Workup should include pulse oximetry, chest radiograph, EKG, pulmonary function tests, complete blood count, iron studies, and cytidine monophosphate testing. Complete cardiac catheterization should occur at centers that specialize in the management of adult congenital heart disease and PAH.", "contents": "Eisenmenger Syndrome -- Evaluation. Workup should include pulse oximetry, chest radiograph, EKG, pulmonary function tests, complete blood count, iron studies, and cytidine monophosphate testing. Complete cardiac catheterization should occur at centers that specialize in the management of adult congenital heart disease and PAH."}
{"id": "article-20936_12", "title": "Eisenmenger Syndrome -- Evaluation", "content": "Loud murmurs may not be present in Eisenmenger syndrome. In such cases, left ventricle pressure may be\u00a0similar to\u00a0right ventricle pressure, creating a very small gradient. Without turbulence, there is no readily appreciable murmur on auscultation.", "contents": "Eisenmenger Syndrome -- Evaluation. Loud murmurs may not be present in Eisenmenger syndrome. In such cases, left ventricle pressure may be\u00a0similar to\u00a0right ventricle pressure, creating a very small gradient. Without turbulence, there is no readily appreciable murmur on auscultation."}
{"id": "article-20936_13", "title": "Eisenmenger Syndrome -- Treatment / Management", "content": "Cardiopulmonary transplantation is curative for Eisenmenger syndrome. However, this is impractical in most\u00a0settings. Pharmacology has improved symptoms but not mortality. Potential pharmaceuticals for the treatment of Eisenmenger syndrome include diuretics, antiarrhythmics, and anticoagulation in some patients. Supplemental oxygen has not definitively shown to have a mortality benefit.", "contents": "Eisenmenger Syndrome -- Treatment / Management. Cardiopulmonary transplantation is curative for Eisenmenger syndrome. However, this is impractical in most\u00a0settings. Pharmacology has improved symptoms but not mortality. Potential pharmaceuticals for the treatment of Eisenmenger syndrome include diuretics, antiarrhythmics, and anticoagulation in some patients. Supplemental oxygen has not definitively shown to have a mortality benefit."}
{"id": "article-20936_14", "title": "Eisenmenger Syndrome -- Treatment / Management", "content": "Vasodilator\u00a0therapies may provide an opportunity for clinical research, and\u00a0studies have shown\u00a0some symptomatic improvement.\u00a0The\u00a0Bosentan\u00a0Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) trial showed improved exercise capacity and symptomatic improvement\u00a0with endothelin antagonists\u00a0in\u00a0patients with ASD, VSD, and PDA with\u00a0Eisenmenger syndrome [1] . Subsequent studies show mortality benefits with sildenafil as well.", "contents": "Eisenmenger Syndrome -- Treatment / Management. Vasodilator\u00a0therapies may provide an opportunity for clinical research, and\u00a0studies have shown\u00a0some symptomatic improvement.\u00a0The\u00a0Bosentan\u00a0Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) trial showed improved exercise capacity and symptomatic improvement\u00a0with endothelin antagonists\u00a0in\u00a0patients with ASD, VSD, and PDA with\u00a0Eisenmenger syndrome [1] . Subsequent studies show mortality benefits with sildenafil as well."}
{"id": "article-20936_15", "title": "Eisenmenger Syndrome -- Treatment / Management", "content": "Warfarin has been classically used for anticoagulation in\u00a0Eisenmenger syndrome. In theory, anticoagulation may\u00a0dispel some of the pathology related to in situ thrombosis inherent with the disease.\u00a0However, the evidence for this\u00a0practice is based on mostly observational studies.", "contents": "Eisenmenger Syndrome -- Treatment / Management. Warfarin has been classically used for anticoagulation in\u00a0Eisenmenger syndrome. In theory, anticoagulation may\u00a0dispel some of the pathology related to in situ thrombosis inherent with the disease.\u00a0However, the evidence for this\u00a0practice is based on mostly observational studies."}
{"id": "article-20936_16", "title": "Eisenmenger Syndrome -- Treatment / Management", "content": "Clinical follow-up should\u00a0focus on checking annual CBC, iron studies, kidney function, and uric acid, with a focus on correcting any abnormalities. Patients\u00a0also\u00a0should be assessed with pulse\u00a0oximetry, both with and without supplemental O2. Any abnormalities\u00a0suggesting hypoxemia warrant further evaluation.", "contents": "Eisenmenger Syndrome -- Treatment / Management. Clinical follow-up should\u00a0focus on checking annual CBC, iron studies, kidney function, and uric acid, with a focus on correcting any abnormalities. Patients\u00a0also\u00a0should be assessed with pulse\u00a0oximetry, both with and without supplemental O2. Any abnormalities\u00a0suggesting hypoxemia warrant further evaluation."}
{"id": "article-20936_17", "title": "Eisenmenger Syndrome -- Treatment / Management", "content": "Surgical correction of the\u00a0causative\u00a0heart defect in adult patients is generally contraindicated [2] . In patients who have developed PAH as a consequence of unrepaired CHD, the defect itself may be acting as a protective measure, preventing worsening of the\u00a0pulmonary\u00a0vascular resistance in the face of increasing right ventricular pressure [3] . In children, the development of pulmonary vascular disease (greater than 6 Woods units/m2) with poor vasodilator response is likely to face post-surgical complications, including right heart failure, increased pulmonary hypertension, and hypertensive crises.", "contents": "Eisenmenger Syndrome -- Treatment / Management. Surgical correction of the\u00a0causative\u00a0heart defect in adult patients is generally contraindicated [2] . In patients who have developed PAH as a consequence of unrepaired CHD, the defect itself may be acting as a protective measure, preventing worsening of the\u00a0pulmonary\u00a0vascular resistance in the face of increasing right ventricular pressure [3] . In children, the development of pulmonary vascular disease (greater than 6 Woods units/m2) with poor vasodilator response is likely to face post-surgical complications, including right heart failure, increased pulmonary hypertension, and hypertensive crises."}
{"id": "article-20936_18", "title": "Eisenmenger Syndrome -- Treatment / Management", "content": "Classically, it is thought to be of little benefit to undergo such risky procedures with\u00a0a plethora of\u00a0potential consequences. Additionally, even with clinical response to vasodilator therapies for the pulmonary arterial hypertension component, there are only a select few case reports that show benefit for the closure of the anatomical defect. However, there is promising evidence that cardiac surgery, along with close peri- and post-operational management of pulmonary vascular resistance with advanced PAH therapies, may improve safety and mitigate downstream problems [4] . [5] [6] [7] [8]", "contents": "Eisenmenger Syndrome -- Treatment / Management. Classically, it is thought to be of little benefit to undergo such risky procedures with\u00a0a plethora of\u00a0potential consequences. Additionally, even with clinical response to vasodilator therapies for the pulmonary arterial hypertension component, there are only a select few case reports that show benefit for the closure of the anatomical defect. However, there is promising evidence that cardiac surgery, along with close peri- and post-operational management of pulmonary vascular resistance with advanced PAH therapies, may improve safety and mitigate downstream problems [4] . [5] [6] [7] [8]"}
{"id": "article-20936_19", "title": "Eisenmenger Syndrome -- Differential Diagnosis", "content": "Due to similar presentation and resemblances of the underlying pathophysiology, other causes of pulmonary hypertension should be ruled out.\u00a0Certain rheumatological and autoimmune diseases, such as mixed connective tissue disorder, scleroderma, and systemic lupus\u00a0erythematosus, may have similar presentations. Hepatitis B, C, and HIV serologies\u00a0also\u00a0must be considered, as these may have systemic vascular presentations.", "contents": "Eisenmenger Syndrome -- Differential Diagnosis. Due to similar presentation and resemblances of the underlying pathophysiology, other causes of pulmonary hypertension should be ruled out.\u00a0Certain rheumatological and autoimmune diseases, such as mixed connective tissue disorder, scleroderma, and systemic lupus\u00a0erythematosus, may have similar presentations. Hepatitis B, C, and HIV serologies\u00a0also\u00a0must be considered, as these may have systemic vascular presentations."}
{"id": "article-20936_20", "title": "Eisenmenger Syndrome -- Prognosis", "content": "Patients with Eisenmenger syndrome will have reduced life expectancies, with high mortality in the third\u00a0and fourth\u00a0decades.\u00a0Ventricular failure, hemoptysis, pregnancy complications, and strokes are common causes of death.", "contents": "Eisenmenger Syndrome -- Prognosis. Patients with Eisenmenger syndrome will have reduced life expectancies, with high mortality in the third\u00a0and fourth\u00a0decades.\u00a0Ventricular failure, hemoptysis, pregnancy complications, and strokes are common causes of death."}
{"id": "article-20936_21", "title": "Eisenmenger Syndrome -- Complications", "content": "In patients with Eisenmenger syndrome,\u00a0certain\u00a0conditions should be avoided such as pregnancy,\u00a0dehydration, isometric exercise, iron deficiency anemia, and significant time spent at high altitudes. When prescribing\u00a0antihypertensives, caution should be exercised when using peripheral vasodilating agents, which may cause worsening of the right-left shunt.", "contents": "Eisenmenger Syndrome -- Complications. In patients with Eisenmenger syndrome,\u00a0certain\u00a0conditions should be avoided such as pregnancy,\u00a0dehydration, isometric exercise, iron deficiency anemia, and significant time spent at high altitudes. When prescribing\u00a0antihypertensives, caution should be exercised when using peripheral vasodilating agents, which may cause worsening of the right-left shunt."}
{"id": "article-20936_22", "title": "Eisenmenger Syndrome -- Complications", "content": "Due to in-situ thrombosis and reactive erythrocytosis, patients with Eisenmenger syndrome are likely to exhibit evidence of both a bleeding diathesis and a hypercoagulable\u00a0state. Patients are at higher risks for paradoxical emboli, in which a clot may theoretically pass through a septal defect from the right heart, bypass the lungs, and instead enter the systemic or cerebrovascular\u00a0circulation. This may result in\u00a0devastating\u00a0cerebrovascular accidents.", "contents": "Eisenmenger Syndrome -- Complications. Due to in-situ thrombosis and reactive erythrocytosis, patients with Eisenmenger syndrome are likely to exhibit evidence of both a bleeding diathesis and a hypercoagulable\u00a0state. Patients are at higher risks for paradoxical emboli, in which a clot may theoretically pass through a septal defect from the right heart, bypass the lungs, and instead enter the systemic or cerebrovascular\u00a0circulation. This may result in\u00a0devastating\u00a0cerebrovascular accidents."}
{"id": "article-20936_23", "title": "Eisenmenger Syndrome -- Pearls and Other Issues", "content": "Loud murmurs may not be present in severe Eisenmenger syndrome due to the lack of pressure gradient between ventricles and therefore low\u00a0turbulence\u00a0that would otherwise produce murmurs. Hypoxemia that is responsive to oxygen therapy should be treated. In women who develop PAH with CHD, pregnancy is contraindicated.", "contents": "Eisenmenger Syndrome -- Pearls and Other Issues. Loud murmurs may not be present in severe Eisenmenger syndrome due to the lack of pressure gradient between ventricles and therefore low\u00a0turbulence\u00a0that would otherwise produce murmurs. Hypoxemia that is responsive to oxygen therapy should be treated. In women who develop PAH with CHD, pregnancy is contraindicated."}
{"id": "article-20936_24", "title": "Eisenmenger Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Eisenmenger syndrome is best managed by an interprofessional team that includes a cardiologist, pulmonologist, cardiac surgeon, internist, thoracic surgeon, and intensivist. There are many causes of the disorder and the key is to treat the primary disorder. Once Eisenmenger syndrome develops, the prognosis is poor. Heart and lung transplant is an option but the lack of donors is a problem. Medications to dilate the pulmonary vasculature are not reliable or consistent in their efficacy. Most patients are dead within 12 to 24 months after the diagnosis is made. [9] [10] [11]", "contents": "Eisenmenger Syndrome -- Enhancing Healthcare Team Outcomes. Eisenmenger syndrome is best managed by an interprofessional team that includes a cardiologist, pulmonologist, cardiac surgeon, internist, thoracic surgeon, and intensivist. There are many causes of the disorder and the key is to treat the primary disorder. Once Eisenmenger syndrome develops, the prognosis is poor. Heart and lung transplant is an option but the lack of donors is a problem. Medications to dilate the pulmonary vasculature are not reliable or consistent in their efficacy. Most patients are dead within 12 to 24 months after the diagnosis is made. [9] [10] [11]"}
{"id": "article-20936_25", "title": "Eisenmenger Syndrome -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Eisenmenger Syndrome -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}